CTNI-24. SINGLE CENTER EXPERIENCE OF DOPAMINE ANTAGONIST ONC-201 FOR RECURRENT H3K27M-MUTANT GLIOBLASTOMA IN ADULTS

Authors: Chukwuyem Ekhator, Ramin Rak, Ramya Tadipatri, Ekokobe Fonkem, Jai Grewal

Published: 2022-11-14

DOI: 10.1093/neuonc/noac209.289

Source: Full article